Type 2 Diabetes

Recent studies show continued benefit in decreasing all-cause mortality from cardiovascular disease.

People with type 2 diabetes found at increased risk for microvascular and macrovascular complications.

Can neuromodulation prevent the onset of metabolic dysfunction associated with the onset of diabetes?

Sitagliptin showed greater glycemic efficacy over dapagliflozin when added onto existing therapy.

The SUSTAIN trials showed significant reductions in weight, but the true reason for the weight loss still unknown.

Scientists find dramatic weight loss may reverse type 2 diabetes in some patients.

New study finds late onset diabetes early sign of pancreatic cancer; African Americans with type 2 diabetes mellitus (T2DM) at a higher risk of developing pancreatic cancer relative to other ethnic groups.

New study shows that within the first two years of a diagnosis of cancer, the risk for type 2 diabetes increases.

Drug shown to reduce risk of CV death or hospitalization for heart failure in adults with CV disease and type 2 diabetes, irrespective of their CV risk at study start.

While there are a number of factors that can negatively impact adherence to self-care in a person with diabetes, this article will focus on diabetes and alcohol: specifically, on how alcohol consumption limits this adherence and affects the overall health of people with diabetes.